Beryl Drugs Limited share price
BSE: BERLDRG
Key numbers
- Market cap
- ₹ 11.8 Cr
- Current price
- ₹ 23.23
- 52-week high / low
- ₹ 28 / 16
- Stock P/E
- 18.7
- Book value
- ₹ 19.5
- Dividend yield
- 0.00%
- ROCE
- 7.1%
- ROE
- 4.3%
- Debt to equity
- 0.25
- Sales growth (3 yrs)
- -11.2%
- Profit growth (3 yrs)
- -18.3%
- 1-year return
- 1.7%
About Beryl Drugs Limited
Beryl Drugs Limited engages in the manufacture and marketing of pharmaceutical products in India. It offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. The company also provides research and development, and contract manufacturing services. It exports its products. The company was incorporated in 1993 and is based in Indore, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 5 | 5 | 4 | 5 | 7 |
| Operating profit | 1 | 1 | -0 | 1 | 1 |
| Net profit | 0 | 0 | -0 | 1 | 0 |
| EPS (₹) | 0.04 | 0.02 | -0.02 | 1.11 | 0.44 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.